動物血漿產品及衍生物市場（依動物類型、衍生物類型、最終用戶及應用）－2025 年至 2030 年全球預測

2024 年獸用血漿產品及衍生物市場價值為 15.2 億美元，預計 2025 年將達到 16.3 億美元，預計到 2030 年將以 7.71% 的複合年成長率成長，達到 23.7 億美元。

動物血漿產品及其衍生物已逐漸成為研究和工業應用的重要焦點。多年來，由於各領域對高品質生物材料的需求不斷擴大，市場經歷了顯著成長。這份深入的報告提供了對該行業的廣泛看法，闡明了從傳統方法到應對現代挑戰的創新、科學主導的解決方案的演變。

該行業目前正處於科學進步和市場需求的十字路口。在生物技術投資和先進研究力度不斷增加的推動下，萃取和精製製程的突破最佳化了動物血漿衍生物的功效。這些改進也轉化為品質和可靠性的提高，使我們的產品在廣泛的應用中不可或缺。隨著需求的成長，新的安全、監管和技術基準也在不斷發展。

這項全面的分析深入探討了關鍵的市場促進因素，為討論變革性轉變和細分見解奠定了基礎。它還檢驗了區域成長的細微差別、主要企業的策略以及決策者的可行見解。強調研究在改進現有產品和探索新衍生物方面的作用，突顯充滿活力和先進的市場。隨著平衡品質、成本和監管要求的需求不斷增加，本概述為深入探索市場光明的未來奠定了基礎。

影響產業格局的變革時期

近年來，獸用血漿產品及衍生市場經歷了幾次變化。製程創新與先進分析工具的結合重塑了生產效率和產品品質。改進的精製方法產生了更一致的衍生產品，有助於滿足嚴格的監管標準和不斷提高的消費者期望。

市場也受到顯著技術進步的影響，例如生產線自動化、品管的人工智慧整合以及流程最佳化的數據驅動方法。這些變化不僅降低了製造成本，而且使生產擴充性，使製造商能夠滿足不斷成長的全球需求。同時，不斷變化的監管環境迫使企業提高透明度和合規性，直接影響其市場營運和長期策略。

同時，業內企業也加大研發投入，探索傳統動物血漿衍生物以外的新應用。多學科合作和夥伴關係的趨勢明顯，這將進一步加速產品創新。隨著新興市場和成熟市場需求的增加，製造商正在重新定義產品系列，以滿足從生物醫學研究到消費性產品的更廣泛的應用。這種策略轉變凸顯了市場的流動性，技術創新和不斷變化的法規為產業的持續成長鋪平了道路。

對不斷發展的市場的關鍵細分洞察

詳細的細分分析揭示了獸用血漿產品及其衍生物的市場動態。該行業根據動物類型、衍生類型、最終用戶和應用進行細分。從動物種類來看，重點是家禽、牛、羊、豬等動物製品。每個類別都具有獨特的特性，可滿足各種應用中的特定產品需求。

此外，衍生型細分包括牛、纖維蛋白原、免疫球蛋白、血清白蛋白、凝血酶等必需產品。這些成分是廣泛生物醫學應用的基礎，有助於研究和治療。最終用戶包括食品製造商、製藥公司和獸醫診所。這種多樣性證明了等離子產品的多功能性和廣泛的適用性，可以解決特定產業的挑戰。

基於應用的市場區隔進一步凸顯了市場的進化性質，產品服務於動物飼料、生物醫學研究、細胞培養基、食品加工等領域。其他應用包括營養補充品、寵物食品產業配方、藥品、化妝品和組織工程。這種市場區隔洞察表明，市場高度專業化，每個細分市場都反映了不同的消費者需求和技術創新，從而推動了產品開發和策略市場定位。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

• 市場動態
  • 驅動程式
    • 人類對動物肉和蛋白質的需求不斷增加
    • 全球消費者對永續和人道動物養殖實踐的認知正在不斷提高
    • 擴大動物血漿在獸醫學的應用
  • 限制因素
    • 對動物血漿產品安全和品質標準的嚴格規定
  • 機會
    • 血漿衍生物在化妝品和護膚中的新興用途，用於創新產品開發
    • 不斷創新生物技術和加工技術，提升動物血漿產品的品質
  • 任務
    • 動物血漿產品合成替代品的可用性
• 市場區隔分析
  • 動物類型：豬血漿產品因其高效率和氨基酸含量而越來越受歡迎。
  • 應用：動物血漿產品在寵物食品產業的重要性日益增加
• 波特五力分析
• PESTEL分析
  • 政治的
  • 經濟
  • 社會
  • 技術的
  • 合法的
  • 環境

6. 動物血漿產品及衍生性商品市場（依動物類型）

• 鳥類
• 牛
• 羊
• 豬

第7章動物血漿產品及衍生性商品市場（依衍生類型）

• 牛
• 纖維蛋白原
• 免疫球蛋白
• 血清白蛋白
• 凝血酶

8. 動物血漿產品及衍生性商品市場（依最終用戶）

• 食品製造商
• 製藥公司
• 獸醫

第9章動物血漿產品及衍生性商品市場：依應用

• 動物飼料
• 生物醫學研究
• 細胞培養基
• 食品加工
• 營養補充品
• 寵物食品業
• 藥品和化妝品
• 組織工程

10.美洲動物血漿產品及衍生物市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

11. 亞太地區動物血漿產品及衍生性商品市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

12. 歐洲、中東及非洲動物血漿產品及衍生性商品市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第13章競爭格局

• 2024年市場佔有率分析
• 2024年FPNV定位矩陣
• 競爭情境分析
• 戰略分析與建議

公司名單

• ACROBiosystems Inc.
• Alfa Laval Corporate AB
• ANZCO Foods Limited
• Auckland BioSciences Ltd.
• BioChemed Services
• Biowest Company
• Bovogen Biologicals Pty Ltd.
• Canvax Reagents SL
• Ebrator Biochemicals Inc.
• Kraeber & Co. GmbH
• Lake Immunogenics, Inc.
• LAMPIRE Biological Laboratories, Inc.
• Meiji Holdings Co., Ltd.
• Merck KGaA
• Pel-Freez, LLC
• Rockland Immunochemicals, Inc.
• Rocky Mountain Biologicals
• Scripps Laboratories, Inc.
• Sigma-Aldrich
• TCS Biosciences Ltd.
• Thermo Fisher Scientific Inc.

The Animal Blood Plasma Products & Derivatives Market was valued at USD 1.52 billion in 2024 and is projected to grow to USD 1.63 billion in 2025, with a CAGR of 7.71%, reaching USD 2.37 billion by 2030.

Animal blood plasma products and derivatives have steadily emerged as a critical focus in both research and industrial applications. Over the years, the market has experienced significant growth driven by the expanding need for high-quality biological materials in various sectors. This in-depth report provides an expansive view of the industry, elucidating the evolution from traditional methodologies to innovative, science-driven solutions that meet modern-day challenges.

The industry now stands at the crossroads of scientific advancement and market demand. Fueled by increased investment in biotechnology and progressive research efforts, significant breakthroughs in extraction and purification processes have optimized the efficacy of animal plasma derivatives. These improvements have also translated into enhanced quality and reliability, making the products indispensable across multiple applications. As the demand grows, new safety, regulatory, and technological benchmarks continue to evolve.

This comprehensive analysis delves into key market drivers, laying the groundwork for a discussion on transformative shifts and segmented insights. The report also examines the nuances of regional growth, the strategies of industry-leading companies, and actionable insights for decision-makers. The role of research in refining existing products while also exploring novel derivatives is underscored, highlighting a market that is both dynamic and forward-thinking. With an ever-increasing need to balance quality, cost, and regulatory requirements, the overview sets the stage for a detailed exploration of the market's promising future.

Transformative Shifts Impacting the Industry Landscape

Recent years have witnessed several transformative shifts in the animal blood plasma products and derivatives market. Innovations in processing techniques combined with advanced analytical tools have reshaped production efficiency and product quality. Enhanced purification methods now allow for greater consistency in derived products, meeting both stringent regulatory criteria and evolving consumer expectations.

The market has also been influenced by notable technological advances, including automation in production lines, integration of artificial intelligence for quality control, and data-driven approaches to process optimization. These changes have not only reduced manufacturing costs but have also improved the scalability of production, enabling manufacturers to meet surging global demand. Simultaneously, evolving regulatory landscapes have compelled companies to enhance transparency and compliance, directly impacting market operations and long-term strategies.

Simultaneously, industry players are increasingly investing in R&D to explore new applications that extend the traditional boundaries of animal plasma derivatives. There is a clear trend toward interdisciplinary collaborations and partnerships which further accelerate product innovation. With increasing demand in both emerging and established markets, manufacturers are redefining product portfolios to address a broader array of applications ranging from biomedical research to consumer products. These strategic shifts underscore a market in flux, where technological innovation and regulatory evolution are paving the way for sustained industry growth.

Key Segmentation Insights in the Evolving Market

A detailed segmentation analysis provides a clear window into the market dynamics of animal blood plasma products and derivatives. The industry is segmented based on animal type, derivative type, end-user, and application. In terms of animal type, significant emphasis is placed on products derived from avian, bovine, ovine, and porcine sources. Each of these categories brings distinct characteristics that cater to specific product needs in various applications.

Furthermore, the derivative type segmentation encompasses essential products such as fetal bovine serum, fibrinogen, immunoglobulin, serum albumin, and thrombin. These components are fundamental in a wide range of biomedical applications, contributing to both research and therapeutic practices. The end-user segmentation spans food manufacturers, pharmaceutical companies, and veterinary services. This diversity demonstrates the versatility and broad applicability of plasma products in addressing industry-specific challenges.

Application-based segmentation further underscores the market's evolving nature, with products making their mark in areas like animal feed, biomedical research, cell culture media, and food processing. Additional applications include nutrition supplements, pet food industry formulations, pharmaceuticals and cosmetics, as well as tissue engineering. This segmentation insight suggests that the market is highly specialized, with each segment reflecting distinct consumer requirements and technological innovations which drive both product development and strategic market positioning.

Based on Animal Type, market is studied across Avian, Bovine, Ovine, and Porcine.

Based on Derivative Type, market is studied across Fetal Bovine Serum, Fibrinogen, Immunoglobulin, Serum Albumin, and Thrombin.

Based on End-User, market is studied across Food Manufacturers, Pharmaceutical Companies, and Veterinary.

Based on Application, market is studied across Animal Feed, Biomedical Research, Cell Culture Media, Food Processing, Nutrition Supplements, Pet Food Industry, Pharmaceuticals & Cosmetics, and Tissue Engineering.

Essential Regional Insights Shaping Market Trends

The animal blood plasma products and derivatives market exhibits noteworthy regional variations that reflect broader economic, regulatory, and technological influences. In the Americas, robust growth is underpinned by advanced research facilities, a strong biotechnology sector, and an aggressive approach to regulatory compliance. These factors ensure sustained demand among established industry players as well as emerging enterprises. Meanwhile, this region benefits from extensive partnerships that drive innovation and set the pace for quality enhancements in product formulations.

Across the region encompassing Europe, the Middle East, and Africa, the market is evolving at a measured pace. Technological advancements and rigorous quality standards have positioned these areas as key contributors to in-depth scientific research and product development. Companies in this region are strategically investing in state-of-the-art infrastructure and R&D, which has resulted in notable improvements in process efficiency and product consistency. The emphasis on research collaboration and regional regulatory alignment has further facilitated market penetration and international trade.

In the Asia-Pacific region, rapid industrialization coupled with a growing demand for high-quality biologics has established an impressive growth trajectory. Technological integration and increasing investment in biotechnology have catalyzed local market innovation, positioning the region as a critical hub for both production and research. The interplay of these regional insights demonstrates that while each geographic area presents unique challenges, collectively they contribute to a resilient and forward-moving market landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation and Market Growth

The landscape of animal blood plasma products and derivatives is bolstered by the significant contributions of several key market players who not only drive innovation but also contribute to market stability and growth. Leading companies such as ACROBiosystems Inc. and Alfa Laval Corporate AB contribute through cutting-edge research and by setting high production standards in the field. Organizations including ANZCO Foods Limited and Auckland BioSciences Ltd. have expanded the market reach by integrating advanced production facilities with global distribution channels.

Other prominent players, including BioChemed Services, Biowest Company, and Bovogen Biologicals Pty Ltd., further enhance the product quality spectrum by focusing on state-of-the-art derivatization practices. Companies like Canvax Reagents S.L. and Ebrator Biochemicals Inc. emphasize innovation and technological frontiers to ensure that products not only meet but exceed industry standards. Moreover, the contributions of Kraeber & Co. GmbH, Lake Immunogenics, Inc., and LAMPIRE Biological Laboratories, Inc. span global markets by combining research excellence with operational efficiency.

In addition, industry leaders such as Meiji Holdings Co., Ltd., Merck KGaA, and Pel-Freez, LLC have cemented their positions through significant R&D investments that drive competitive advantages. The market also benefits from the strategic insights provided by organizations like Rockland Immunochemicals, Inc., Rocky Mountain Biologicals, Scripps Laboratories, Inc., and Sigma-Aldrich. Collaborations and technological synergies with TCS Biosciences Ltd. and Thermo Fisher Scientific Inc. have led to innovative product lines and enhanced service offerings, thereby reinforcing the market's future prospects.

The report delves into recent significant developments in the Animal Blood Plasma Products & Derivatives Market, highlighting leading vendors and their innovative profiles. These include ACROBiosystems Inc., Alfa Laval Corporate AB, ANZCO Foods Limited, Auckland BioSciences Ltd., BioChemed Services, Biowest Company, Bovogen Biologicals Pty Ltd., Canvax Reagents S.L., Ebrator Biochemicals Inc., Kraeber & Co. GmbH, Lake Immunogenics, Inc., LAMPIRE Biological Laboratories, Inc., Meiji Holdings Co., Ltd., Merck KGaA, Pel-Freez, LLC, Rockland Immunochemicals, Inc., Rocky Mountain Biologicals, Scripps Laboratories, Inc., Sigma-Aldrich, TCS Biosciences Ltd., and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders

Industry decision-makers are positioned to accelerate growth by focusing on advancements in R&D and by streamlining operational efficiencies. Leaders should prioritize investment in next-generation processing technologies that elevate product purity and yield. It is essential to foster strategic partnerships that bridge research institutions with production facilities to harness cutting-edge developments and meet the changing market demands. By actively monitoring regulatory updates and aligning with global standards, companies can mitigate compliance risks while maintaining a competitive edge.

Furthermore, optimizing the supply chain and enhancing quality control measures will support timely market entry and reduce production bottlenecks. Establishing robust data analytics frameworks provides actionable intelligence that informs decision-making processes and tailors product development to the precise needs of diverse market segments. Ultimately, a focused approach that couples technological innovation with operational excellence will enable industry leaders to sustain growth and capitalize on emerging opportunities.

Conclusion and Future Market Prospects

The analysis of animal blood plasma products and derivatives reveals an industry rich in opportunity and resilient against market fluctuations. Driven by technological advancements, insightful segmentation, and an evolving regulatory environment, the market continues to demonstrate robust growth. The integration of innovative production techniques and diversification across various applications has created an ecosystem where research and development lead to tangible, market-ready outcomes.

As the industry moves forward, it is clear that embracing both regional nuances and the strategic insights of key companies will be instrumental in shaping future directions. The balance between quality enhancements and regulatory compliance continues to be a defining factor in enabling market leaders to achieve sustained success. With continued innovation and strategic collaborations, the prospects for the market remain highly promising, offering growth potential that is both extensive and diverse.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for animal meat and protein among human population
    • 5.1.1.2. Rising consumer awareness concerning sustainable and humane animal farming practices globally
    • 5.1.1.3. Expanding utilization of animal blood plasma in veterinary care applications
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulations for safety and quality standards for animal blood plasma products
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging use of blood plasma derivatives in cosmetics and skincare for innovative product development
    • 5.1.3.2. Ongoing innovations in biotechnology and processing techniques to improve the quality of animal blood plasma products
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of synthetic alternatives to animal blood plasma products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Animal Type: Rising preference for porcine plasma products owing to high efficiency and amino acid
  • 5.2.2. Application: Increasing significance of animal blood plasma products in pet food industry
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Blood Plasma Products & Derivatives Market, by Animal Type

• 6.1. Introduction
• 6.2. Avian
• 6.3. Bovine
• 6.4. Ovine
• 6.5. Porcine

7. Animal Blood Plasma Products & Derivatives Market, by Derivative Type

• 7.1. Introduction
• 7.2. Fetal Bovine Serum
• 7.3. Fibrinogen
• 7.4. Immunoglobulin
• 7.5. Serum Albumin
• 7.6. Thrombin

8. Animal Blood Plasma Products & Derivatives Market, by End-User

• 8.1. Introduction
• 8.2. Food Manufacturers
• 8.3. Pharmaceutical Companies
• 8.4. Veterinary

9. Animal Blood Plasma Products & Derivatives Market, by Application

• 9.1. Introduction
• 9.2. Animal Feed
• 9.3. Biomedical Research
• 9.4. Cell Culture Media
• 9.5. Food Processing
• 9.6. Nutrition Supplements
• 9.7. Pet Food Industry
• 9.8. Pharmaceuticals & Cosmetics
• 9.9. Tissue Engineering

10. Americas Animal Blood Plasma Products & Derivatives Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Animal Blood Plasma Products & Derivatives Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Animal Blood Plasma Products & Derivatives Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Gemini Bioproducts expands its portfolio by acquiring Bio-Techne's key fetal bovine serum brands
  • 13.3.2. FDA clearance of PrecisePRP Canine transform veterinary care with innovative platelet-rich plasma solution
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ACROBiosystems Inc.
• 2. Alfa Laval Corporate AB
• 3. ANZCO Foods Limited
• 4. Auckland BioSciences Ltd.
• 5. BioChemed Services
• 6. Biowest Company
• 7. Bovogen Biologicals Pty Ltd.
• 8. Canvax Reagents S.L.
• 9. Ebrator Biochemicals Inc.
• 10. Kraeber & Co. GmbH
• 11. Lake Immunogenics, Inc.
• 12. LAMPIRE Biological Laboratories, Inc.
• 13. Meiji Holdings Co., Ltd.
• 14. Merck KGaA
• 15. Pel-Freez, LLC
• 16. Rockland Immunochemicals, Inc.
• 17. Rocky Mountain Biologicals
• 18. Scripps Laboratories, Inc.
• 19. Sigma-Aldrich
• 20. TCS Biosciences Ltd.
• 21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET MULTI-CURRENCY
• FIGURE 2. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET MULTI-LANGUAGE
• FIGURE 3. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET RESEARCH PROCESS
• FIGURE 4. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET DYNAMICS
• TABLE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CANADA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. INDIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. MALAYSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. PHILIPPINES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SINGAPORE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. SOUTH KOREA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. TAIWAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. THAILAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. VIETNAM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. DENMARK ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. EGYPT ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. FINLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. FRANCE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. GERMANY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. ISRAEL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 140. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 141. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. ITALY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. NETHERLANDS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. NIGERIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 153. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. NORWAY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 156. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. POLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 160. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 161. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. QATAR ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 165. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. RUSSIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SAUDI ARABIA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. SPAIN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. SWEDEN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 185. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. SWITZERLAND ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. TURKEY ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. UNITED ARAB EMIRATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. UNITED KINGDOM ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 200. ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024